Global Mepolizumab Supply, Demand and Key Producers, 2026-2032
The global Mepolizumab market size is expected to reach $ 7259 million by 2032, rising at a market growth of 16.3% CAGR during the forecast period (2026-2032).
Mepolizumab is a humanized anti?interleukin?5 (IL?5) monoclonal antibody drug. It specifically targets and binds to the IL?5 cytokine, blocks its combination with receptors on the surface of eosinophils, and inhibits the activation, proliferation and survival of eosinophils, thereby reducing eosinophilic inflammatory responses in the respiratory tract and the whole body. It is mainly applied in the treatment of inflammatory diseases such as eosinophilic asthma and chronic rhinosinusitis with nasal polyps. With stable clinical efficacy and favorable safety, it can effectively reduce the risk of severe exacerbations and provide a long?acting targeted treatment option for eosinophil?related respiratory diseases.In 2025, global Mepolizumab (Nucala) production reached approximately 1.71 million vials.
Mepolizumab, the world’s first approved anti?IL?5 monoclonal antibody, targets eosinophil?related diseases mediated by interleukin?5. It has built a diversified product portfolio centered on severe asthma, with gradually expanded indications including chronic rhinosinusitis with nasal polyps and eosinophilic granulomatosis with polyangiitis. Its market development is driven by the popularization of precision diagnosis and treatment as well as the general shift toward biological agents. Global regulatory authorities continue to expand its applicable populations and age ranges, meanwhile promoting its penetration from hospital settings to outpatient and home care scenarios. In terms of competition, GSK occupies a leading position, continuously optimizing its indication spectrum through clinical research and developing next?generation long?acting formulations to improve patient compliance and market competitiveness. Regional market growth benefits from improved medical infrastructure and rising awareness of rare and refractory inflammatory diseases, with emerging markets such as the Asia?Pacific region showing great growth potential. Overall, key market drivers include improved diagnostic capabilities, greater accessibility of biological drugs, and optimized long?term treatment costs. Major challenges involve difficulties in target patient screening, inconsistent reimbursement policies, and competition from similar therapeutic drugs. The overall industry development is characterized by indication expansion, regional market penetration and continuous product iteration.
This report studies the global Mepolizumab production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Mepolizumab and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Mepolizumab that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Mepolizumab total production and demand, 2021-2032, (Units)
Global Mepolizumab total production value, 2021-2032, (USD Million)
Global Mepolizumab production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Mepolizumab consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Mepolizumab domestic production, consumption, key domestic manufacturers and share
Global Mepolizumab production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Mepolizumab production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Mepolizumab production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Mepolizumab market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, GlaxoSmithKline, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Mepolizumab market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Mepolizumab Market, By Region:
1. How big is the global Mepolizumab market?
2. What is the demand of the global Mepolizumab market?
3. What is the year over year growth of the global Mepolizumab market?
4. What is the production and production value of the global Mepolizumab market?
5. Who are the key producers in the global Mepolizumab market?
6. What are the growth factors driving the market demand?
Mepolizumab is a humanized anti?interleukin?5 (IL?5) monoclonal antibody drug. It specifically targets and binds to the IL?5 cytokine, blocks its combination with receptors on the surface of eosinophils, and inhibits the activation, proliferation and survival of eosinophils, thereby reducing eosinophilic inflammatory responses in the respiratory tract and the whole body. It is mainly applied in the treatment of inflammatory diseases such as eosinophilic asthma and chronic rhinosinusitis with nasal polyps. With stable clinical efficacy and favorable safety, it can effectively reduce the risk of severe exacerbations and provide a long?acting targeted treatment option for eosinophil?related respiratory diseases.In 2025, global Mepolizumab (Nucala) production reached approximately 1.71 million vials.
Mepolizumab, the world’s first approved anti?IL?5 monoclonal antibody, targets eosinophil?related diseases mediated by interleukin?5. It has built a diversified product portfolio centered on severe asthma, with gradually expanded indications including chronic rhinosinusitis with nasal polyps and eosinophilic granulomatosis with polyangiitis. Its market development is driven by the popularization of precision diagnosis and treatment as well as the general shift toward biological agents. Global regulatory authorities continue to expand its applicable populations and age ranges, meanwhile promoting its penetration from hospital settings to outpatient and home care scenarios. In terms of competition, GSK occupies a leading position, continuously optimizing its indication spectrum through clinical research and developing next?generation long?acting formulations to improve patient compliance and market competitiveness. Regional market growth benefits from improved medical infrastructure and rising awareness of rare and refractory inflammatory diseases, with emerging markets such as the Asia?Pacific region showing great growth potential. Overall, key market drivers include improved diagnostic capabilities, greater accessibility of biological drugs, and optimized long?term treatment costs. Major challenges involve difficulties in target patient screening, inconsistent reimbursement policies, and competition from similar therapeutic drugs. The overall industry development is characterized by indication expansion, regional market penetration and continuous product iteration.
This report studies the global Mepolizumab production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Mepolizumab and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Mepolizumab that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Mepolizumab total production and demand, 2021-2032, (Units)
Global Mepolizumab total production value, 2021-2032, (USD Million)
Global Mepolizumab production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Mepolizumab consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Mepolizumab domestic production, consumption, key domestic manufacturers and share
Global Mepolizumab production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Mepolizumab production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Mepolizumab production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Mepolizumab market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, GlaxoSmithKline, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Mepolizumab market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Mepolizumab Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 100mg Pre?filled Syringe
- 100mg Lyophilized Powder for Injection
- Combination of Mepolizumab and Inhaled Corticosteroids
- Combination of Mepolizumab and LABA
- Subcutaneous Injection
- Subcutaneous Infusion
- Hospital
- Retail
- Online
- Severe Eosinophilic Asthma
- Chronic Rhinosinusitis With Nasal Polyps
- Eosinophilic Granulomatosis With Polyangiitis
- Others
- GSK, GlaxoSmithKline
1. How big is the global Mepolizumab market?
2. What is the demand of the global Mepolizumab market?
3. What is the year over year growth of the global Mepolizumab market?
4. What is the production and production value of the global Mepolizumab market?
5. Who are the key producers in the global Mepolizumab market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Mepolizumab Introduction
1.2 World Mepolizumab Supply & Forecast
1.2.1 World Mepolizumab Production Value (2021 & 2025 & 2032)
1.2.2 World Mepolizumab Production (2021-2032)
1.2.3 World Mepolizumab Pricing Trends (2021-2032)
1.3 World Mepolizumab Production by Region (Based on Production Site)
1.3.1 World Mepolizumab Production Value by Region (2021-2032)
1.3.2 World Mepolizumab Production by Region (2021-2032)
1.3.3 World Mepolizumab Average Price by Region (2021-2032)
1.3.4 North America Mepolizumab Production (2021-2032)
1.3.5 Europe Mepolizumab Production (2021-2032)
1.3.6 China Mepolizumab Production (2021-2032)
1.3.7 Japan Mepolizumab Production (2021-2032)
1.3.8 India Mepolizumab Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Mepolizumab Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Mepolizumab Major Market Trends
2 DEMAND SUMMARY
2.1 World Mepolizumab Demand (2021-2032)
2.2 World Mepolizumab Consumption by Region
2.2.1 World Mepolizumab Consumption by Region (2021-2026)
2.2.2 World Mepolizumab Consumption Forecast by Region (2027-2032)
2.3 United States Mepolizumab Consumption (2021-2032)
2.4 China Mepolizumab Consumption (2021-2032)
2.5 Europe Mepolizumab Consumption (2021-2032)
2.6 Japan Mepolizumab Consumption (2021-2032)
2.7 South Korea Mepolizumab Consumption (2021-2032)
2.8 ASEAN Mepolizumab Consumption (2021-2032)
2.9 India Mepolizumab Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Mepolizumab Production Value by Manufacturer (2021-2026)
3.2 World Mepolizumab Production by Manufacturer (2021-2026)
3.3 World Mepolizumab Average Price by Manufacturer (2021-2026)
3.4 Mepolizumab Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Mepolizumab Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Mepolizumab in 2025
3.5.3 Global Concentration Ratios (CR8) for Mepolizumab in 2025
3.6 Mepolizumab Market: Overall Company Footprint Analysis
3.6.1 Mepolizumab Market: Region Footprint
3.6.2 Mepolizumab Market: Company Product Type Footprint
3.6.3 Mepolizumab Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Mepolizumab Production Value Comparison
4.1.1 United States VS China: Mepolizumab Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Mepolizumab Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Mepolizumab Production Comparison
4.2.1 United States VS China: Mepolizumab Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Mepolizumab Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Mepolizumab Consumption Comparison
4.3.1 United States VS China: Mepolizumab Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Mepolizumab Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Mepolizumab Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Mepolizumab Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Mepolizumab Production Value (2021-2026)
4.4.3 United States Based Manufacturers Mepolizumab Production (2021-2026)
4.5 China Based Mepolizumab Manufacturers and Market Share
4.5.1 China Based Mepolizumab Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Mepolizumab Production Value (2021-2026)
4.5.3 China Based Manufacturers Mepolizumab Production (2021-2026)
4.6 Rest of World Based Mepolizumab Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Mepolizumab Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Mepolizumab Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Mepolizumab Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Mepolizumab Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 100mg Pre?filled Syringe
5.2.2 100mg Lyophilized Powder for Injection
5.3 Market Segment by Type
5.3.1 World Mepolizumab Production by Type (2021-2032)
5.3.2 World Mepolizumab Production Value by Type (2021-2032)
5.3.3 World Mepolizumab Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY COMBINATION THERAPY
6.1 World Mepolizumab Market Size Overview by Combination Therapy: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Combination Therapy
6.2.1 Combination of Mepolizumab and Inhaled Corticosteroids
6.2.2 Combination of Mepolizumab and LABA
6.3 Market Segment by Combination Therapy
6.3.1 World Mepolizumab Production by Combination Therapy (2021-2032)
6.3.2 World Mepolizumab Production Value by Combination Therapy (2021-2032)
6.3.3 World Mepolizumab Average Price by Combination Therapy (2021-2032)
7 MARKET ANALYSIS BY ROUTE OF ADMINISTRATIO
7.1 World Mepolizumab Market Size Overview by Route of Administratio: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Route of Administratio
7.2.1 Subcutaneous Injection
7.2.2 Subcutaneous Infusion
7.3 Market Segment by Route of Administratio
7.3.1 World Mepolizumab Production by Route of Administratio (2021-2032)
7.3.2 World Mepolizumab Production Value by Route of Administratio (2021-2032)
7.3.3 World Mepolizumab Average Price by Route of Administratio (2021-2032)
8 MARKET ANALYSIS BY SALES CHANNEL
8.1 World Mepolizumab Market Size Overview by Sales Channel: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Sales Channel
8.2.1 Hospital
8.2.2 Retail
8.2.3 Online
8.3 Market Segment by Sales Channel
8.3.1 World Mepolizumab Production by Sales Channel (2021-2032)
8.3.2 World Mepolizumab Production Value by Sales Channel (2021-2032)
8.3.3 World Mepolizumab Average Price by Sales Channel (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Mepolizumab Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Severe Eosinophilic Asthma
9.2.2 Chronic Rhinosinusitis With Nasal Polyps
9.2.3 Eosinophilic Granulomatosis With Polyangiitis
9.2.4 Others
9.3 Market Segment by Application
9.3.1 World Mepolizumab Production by Application (2021-2032)
9.3.2 World Mepolizumab Production Value by Application (2021-2032)
9.3.3 World Mepolizumab Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 GSK, GlaxoSmithKline
10.1.1 GSK, GlaxoSmithKline Details
10.1.2 GSK, GlaxoSmithKline Major Business
10.1.3 GSK, GlaxoSmithKline Mepolizumab Product and Services
10.1.4 GSK, GlaxoSmithKline Mepolizumab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 GSK, GlaxoSmithKline Recent Developments/Updates
10.1.6 GSK, GlaxoSmithKline Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Mepolizumab Industry Chain
11.2 Mepolizumab Upstream Analysis
11.2.1 Mepolizumab Core Raw Materials
11.2.2 Main Manufacturers of Mepolizumab Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Mepolizumab Production Mode
11.6 Mepolizumab Procurement Model
11.7 Mepolizumab Industry Sales Model and Sales Channels
11.7.1 Mepolizumab Sales Model
11.7.2 Mepolizumab Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
1.1 Mepolizumab Introduction
1.2 World Mepolizumab Supply & Forecast
1.2.1 World Mepolizumab Production Value (2021 & 2025 & 2032)
1.2.2 World Mepolizumab Production (2021-2032)
1.2.3 World Mepolizumab Pricing Trends (2021-2032)
1.3 World Mepolizumab Production by Region (Based on Production Site)
1.3.1 World Mepolizumab Production Value by Region (2021-2032)
1.3.2 World Mepolizumab Production by Region (2021-2032)
1.3.3 World Mepolizumab Average Price by Region (2021-2032)
1.3.4 North America Mepolizumab Production (2021-2032)
1.3.5 Europe Mepolizumab Production (2021-2032)
1.3.6 China Mepolizumab Production (2021-2032)
1.3.7 Japan Mepolizumab Production (2021-2032)
1.3.8 India Mepolizumab Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Mepolizumab Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Mepolizumab Major Market Trends
2 DEMAND SUMMARY
2.1 World Mepolizumab Demand (2021-2032)
2.2 World Mepolizumab Consumption by Region
2.2.1 World Mepolizumab Consumption by Region (2021-2026)
2.2.2 World Mepolizumab Consumption Forecast by Region (2027-2032)
2.3 United States Mepolizumab Consumption (2021-2032)
2.4 China Mepolizumab Consumption (2021-2032)
2.5 Europe Mepolizumab Consumption (2021-2032)
2.6 Japan Mepolizumab Consumption (2021-2032)
2.7 South Korea Mepolizumab Consumption (2021-2032)
2.8 ASEAN Mepolizumab Consumption (2021-2032)
2.9 India Mepolizumab Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Mepolizumab Production Value by Manufacturer (2021-2026)
3.2 World Mepolizumab Production by Manufacturer (2021-2026)
3.3 World Mepolizumab Average Price by Manufacturer (2021-2026)
3.4 Mepolizumab Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Mepolizumab Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Mepolizumab in 2025
3.5.3 Global Concentration Ratios (CR8) for Mepolizumab in 2025
3.6 Mepolizumab Market: Overall Company Footprint Analysis
3.6.1 Mepolizumab Market: Region Footprint
3.6.2 Mepolizumab Market: Company Product Type Footprint
3.6.3 Mepolizumab Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Mepolizumab Production Value Comparison
4.1.1 United States VS China: Mepolizumab Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Mepolizumab Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Mepolizumab Production Comparison
4.2.1 United States VS China: Mepolizumab Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Mepolizumab Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Mepolizumab Consumption Comparison
4.3.1 United States VS China: Mepolizumab Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Mepolizumab Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Mepolizumab Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Mepolizumab Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Mepolizumab Production Value (2021-2026)
4.4.3 United States Based Manufacturers Mepolizumab Production (2021-2026)
4.5 China Based Mepolizumab Manufacturers and Market Share
4.5.1 China Based Mepolizumab Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Mepolizumab Production Value (2021-2026)
4.5.3 China Based Manufacturers Mepolizumab Production (2021-2026)
4.6 Rest of World Based Mepolizumab Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Mepolizumab Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Mepolizumab Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Mepolizumab Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Mepolizumab Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 100mg Pre?filled Syringe
5.2.2 100mg Lyophilized Powder for Injection
5.3 Market Segment by Type
5.3.1 World Mepolizumab Production by Type (2021-2032)
5.3.2 World Mepolizumab Production Value by Type (2021-2032)
5.3.3 World Mepolizumab Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY COMBINATION THERAPY
6.1 World Mepolizumab Market Size Overview by Combination Therapy: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Combination Therapy
6.2.1 Combination of Mepolizumab and Inhaled Corticosteroids
6.2.2 Combination of Mepolizumab and LABA
6.3 Market Segment by Combination Therapy
6.3.1 World Mepolizumab Production by Combination Therapy (2021-2032)
6.3.2 World Mepolizumab Production Value by Combination Therapy (2021-2032)
6.3.3 World Mepolizumab Average Price by Combination Therapy (2021-2032)
7 MARKET ANALYSIS BY ROUTE OF ADMINISTRATIO
7.1 World Mepolizumab Market Size Overview by Route of Administratio: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Route of Administratio
7.2.1 Subcutaneous Injection
7.2.2 Subcutaneous Infusion
7.3 Market Segment by Route of Administratio
7.3.1 World Mepolizumab Production by Route of Administratio (2021-2032)
7.3.2 World Mepolizumab Production Value by Route of Administratio (2021-2032)
7.3.3 World Mepolizumab Average Price by Route of Administratio (2021-2032)
8 MARKET ANALYSIS BY SALES CHANNEL
8.1 World Mepolizumab Market Size Overview by Sales Channel: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Sales Channel
8.2.1 Hospital
8.2.2 Retail
8.2.3 Online
8.3 Market Segment by Sales Channel
8.3.1 World Mepolizumab Production by Sales Channel (2021-2032)
8.3.2 World Mepolizumab Production Value by Sales Channel (2021-2032)
8.3.3 World Mepolizumab Average Price by Sales Channel (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Mepolizumab Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Severe Eosinophilic Asthma
9.2.2 Chronic Rhinosinusitis With Nasal Polyps
9.2.3 Eosinophilic Granulomatosis With Polyangiitis
9.2.4 Others
9.3 Market Segment by Application
9.3.1 World Mepolizumab Production by Application (2021-2032)
9.3.2 World Mepolizumab Production Value by Application (2021-2032)
9.3.3 World Mepolizumab Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 GSK, GlaxoSmithKline
10.1.1 GSK, GlaxoSmithKline Details
10.1.2 GSK, GlaxoSmithKline Major Business
10.1.3 GSK, GlaxoSmithKline Mepolizumab Product and Services
10.1.4 GSK, GlaxoSmithKline Mepolizumab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 GSK, GlaxoSmithKline Recent Developments/Updates
10.1.6 GSK, GlaxoSmithKline Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Mepolizumab Industry Chain
11.2 Mepolizumab Upstream Analysis
11.2.1 Mepolizumab Core Raw Materials
11.2.2 Main Manufacturers of Mepolizumab Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Mepolizumab Production Mode
11.6 Mepolizumab Procurement Model
11.7 Mepolizumab Industry Sales Model and Sales Channels
11.7.1 Mepolizumab Sales Model
11.7.2 Mepolizumab Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
LIST OF TABLES
Table 1. World Mepolizumab Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Mepolizumab Production Value by Region (2021-2026) & (USD Million)
Table 3. World Mepolizumab Production Value by Region (2027-2032) & (USD Million)
Table 4. World Mepolizumab Production Value Market Share by Region (2021-2026)
Table 5. World Mepolizumab Production Value Market Share by Region (2027-2032)
Table 6. World Mepolizumab Production by Region (2021-2026) & (Units)
Table 7. World Mepolizumab Production by Region (2027-2032) & (Units)
Table 8. World Mepolizumab Production Market Share by Region (2021-2026)
Table 9. World Mepolizumab Production Market Share by Region (2027-2032)
Table 10. World Mepolizumab Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Mepolizumab Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Mepolizumab Major Market Trends
Table 13. World Mepolizumab Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Mepolizumab Consumption by Region (2021-2026) & (Units)
Table 15. World Mepolizumab Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Mepolizumab Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Mepolizumab Producers in 2025
Table 18. World Mepolizumab Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Mepolizumab Producers in 2025
Table 20. World Mepolizumab Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Mepolizumab Company Evaluation Quadrant
Table 22. World Mepolizumab Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Mepolizumab Production Site of Key Manufacturer
Table 24. Mepolizumab Market: Company Product Type Footprint
Table 25. Mepolizumab Market: Company Product Application Footprint
Table 26. Mepolizumab Competitive Factors
Table 27. Mepolizumab New Entrant and Capacity Expansion Plans
Table 28. Mepolizumab Mergers & Acquisitions Activity
Table 29. United States VS China Mepolizumab Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Mepolizumab Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Mepolizumab Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Mepolizumab Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Mepolizumab Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Mepolizumab Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Mepolizumab Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Mepolizumab Production Market Share (2021-2026)
Table 37. China Based Mepolizumab Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Mepolizumab Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Mepolizumab Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Mepolizumab Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Mepolizumab Production Market Share (2021-2026)
Table 42. Rest of World Based Mepolizumab Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Mepolizumab Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Mepolizumab Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Mepolizumab Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Mepolizumab Production Market Share (2021-2026)
Table 47. World Mepolizumab Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Mepolizumab Production by Type (2021-2026) & (Units)
Table 49. World Mepolizumab Production by Type (2027-2032) & (Units)
Table 50. World Mepolizumab Production Value by Type (2021-2026) & (USD Million)
Table 51. World Mepolizumab Production Value by Type (2027-2032) & (USD Million)
Table 52. World Mepolizumab Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Mepolizumab Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Mepolizumab Production Value by Combination Therapy, (USD Million), 2021 & 2025 & 2032
Table 55. World Mepolizumab Production by Combination Therapy (2021-2026) & (Units)
Table 56. World Mepolizumab Production by Combination Therapy (2027-2032) & (Units)
Table 57. World Mepolizumab Production Value by Combination Therapy (2021-2026) & (USD Million)
Table 58. World Mepolizumab Production Value by Combination Therapy (2027-2032) & (USD Million)
Table 59. World Mepolizumab Average Price by Combination Therapy (2021-2026) & (US$/Unit)
Table 60. World Mepolizumab Average Price by Combination Therapy (2027-2032) & (US$/Unit)
Table 61. World Mepolizumab Production Value by Route of Administratio, (USD Million), 2021 & 2025 & 2032
Table 62. World Mepolizumab Production by Route of Administratio (2021-2026) & (Units)
Table 63. World Mepolizumab Production by Route of Administratio (2027-2032) & (Units)
Table 64. World Mepolizumab Production Value by Route of Administratio (2021-2026) & (USD Million)
Table 65. World Mepolizumab Production Value by Route of Administratio (2027-2032) & (USD Million)
Table 66. World Mepolizumab Average Price by Route of Administratio (2021-2026) & (US$/Unit)
Table 67. World Mepolizumab Average Price by Route of Administratio (2027-2032) & (US$/Unit)
Table 68. World Mepolizumab Production Value by Sales Channel, (USD Million), 2021 & 2025 & 2032
Table 69. World Mepolizumab Production by Sales Channel (2021-2026) & (Units)
Table 70. World Mepolizumab Production by Sales Channel (2027-2032) & (Units)
Table 71. World Mepolizumab Production Value by Sales Channel (2021-2026) & (USD Million)
Table 72. World Mepolizumab Production Value by Sales Channel (2027-2032) & (USD Million)
Table 73. World Mepolizumab Average Price by Sales Channel (2021-2026) & (US$/Unit)
Table 74. World Mepolizumab Average Price by Sales Channel (2027-2032) & (US$/Unit)
Table 75. World Mepolizumab Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Mepolizumab Production by Application (2021-2026) & (Units)
Table 77. World Mepolizumab Production by Application (2027-2032) & (Units)
Table 78. World Mepolizumab Production Value by Application (2021-2026) & (USD Million)
Table 79. World Mepolizumab Production Value by Application (2027-2032) & (USD Million)
Table 80. World Mepolizumab Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World Mepolizumab Average Price by Application (2027-2032) & (US$/Unit)
Table 82. GSK, GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 83. GSK, GlaxoSmithKline Major Business
Table 84. GSK, GlaxoSmithKline Mepolizumab Product and Services
Table 85. GSK, GlaxoSmithKline Mepolizumab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. GSK, GlaxoSmithKline Recent Developments/Updates
Table 87. GSK, GlaxoSmithKline Competitive Strengths & Weaknesses
Table 88. Global Key Players of Mepolizumab Upstream (Raw Materials)
Table 89. Global Mepolizumab Typical Customers
Table 90. Mepolizumab Typical Distributors
Table 1. World Mepolizumab Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Mepolizumab Production Value by Region (2021-2026) & (USD Million)
Table 3. World Mepolizumab Production Value by Region (2027-2032) & (USD Million)
Table 4. World Mepolizumab Production Value Market Share by Region (2021-2026)
Table 5. World Mepolizumab Production Value Market Share by Region (2027-2032)
Table 6. World Mepolizumab Production by Region (2021-2026) & (Units)
Table 7. World Mepolizumab Production by Region (2027-2032) & (Units)
Table 8. World Mepolizumab Production Market Share by Region (2021-2026)
Table 9. World Mepolizumab Production Market Share by Region (2027-2032)
Table 10. World Mepolizumab Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Mepolizumab Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Mepolizumab Major Market Trends
Table 13. World Mepolizumab Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Mepolizumab Consumption by Region (2021-2026) & (Units)
Table 15. World Mepolizumab Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Mepolizumab Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Mepolizumab Producers in 2025
Table 18. World Mepolizumab Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Mepolizumab Producers in 2025
Table 20. World Mepolizumab Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Mepolizumab Company Evaluation Quadrant
Table 22. World Mepolizumab Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Mepolizumab Production Site of Key Manufacturer
Table 24. Mepolizumab Market: Company Product Type Footprint
Table 25. Mepolizumab Market: Company Product Application Footprint
Table 26. Mepolizumab Competitive Factors
Table 27. Mepolizumab New Entrant and Capacity Expansion Plans
Table 28. Mepolizumab Mergers & Acquisitions Activity
Table 29. United States VS China Mepolizumab Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Mepolizumab Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Mepolizumab Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Mepolizumab Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Mepolizumab Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Mepolizumab Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Mepolizumab Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Mepolizumab Production Market Share (2021-2026)
Table 37. China Based Mepolizumab Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Mepolizumab Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Mepolizumab Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Mepolizumab Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Mepolizumab Production Market Share (2021-2026)
Table 42. Rest of World Based Mepolizumab Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Mepolizumab Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Mepolizumab Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Mepolizumab Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Mepolizumab Production Market Share (2021-2026)
Table 47. World Mepolizumab Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Mepolizumab Production by Type (2021-2026) & (Units)
Table 49. World Mepolizumab Production by Type (2027-2032) & (Units)
Table 50. World Mepolizumab Production Value by Type (2021-2026) & (USD Million)
Table 51. World Mepolizumab Production Value by Type (2027-2032) & (USD Million)
Table 52. World Mepolizumab Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Mepolizumab Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Mepolizumab Production Value by Combination Therapy, (USD Million), 2021 & 2025 & 2032
Table 55. World Mepolizumab Production by Combination Therapy (2021-2026) & (Units)
Table 56. World Mepolizumab Production by Combination Therapy (2027-2032) & (Units)
Table 57. World Mepolizumab Production Value by Combination Therapy (2021-2026) & (USD Million)
Table 58. World Mepolizumab Production Value by Combination Therapy (2027-2032) & (USD Million)
Table 59. World Mepolizumab Average Price by Combination Therapy (2021-2026) & (US$/Unit)
Table 60. World Mepolizumab Average Price by Combination Therapy (2027-2032) & (US$/Unit)
Table 61. World Mepolizumab Production Value by Route of Administratio, (USD Million), 2021 & 2025 & 2032
Table 62. World Mepolizumab Production by Route of Administratio (2021-2026) & (Units)
Table 63. World Mepolizumab Production by Route of Administratio (2027-2032) & (Units)
Table 64. World Mepolizumab Production Value by Route of Administratio (2021-2026) & (USD Million)
Table 65. World Mepolizumab Production Value by Route of Administratio (2027-2032) & (USD Million)
Table 66. World Mepolizumab Average Price by Route of Administratio (2021-2026) & (US$/Unit)
Table 67. World Mepolizumab Average Price by Route of Administratio (2027-2032) & (US$/Unit)
Table 68. World Mepolizumab Production Value by Sales Channel, (USD Million), 2021 & 2025 & 2032
Table 69. World Mepolizumab Production by Sales Channel (2021-2026) & (Units)
Table 70. World Mepolizumab Production by Sales Channel (2027-2032) & (Units)
Table 71. World Mepolizumab Production Value by Sales Channel (2021-2026) & (USD Million)
Table 72. World Mepolizumab Production Value by Sales Channel (2027-2032) & (USD Million)
Table 73. World Mepolizumab Average Price by Sales Channel (2021-2026) & (US$/Unit)
Table 74. World Mepolizumab Average Price by Sales Channel (2027-2032) & (US$/Unit)
Table 75. World Mepolizumab Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Mepolizumab Production by Application (2021-2026) & (Units)
Table 77. World Mepolizumab Production by Application (2027-2032) & (Units)
Table 78. World Mepolizumab Production Value by Application (2021-2026) & (USD Million)
Table 79. World Mepolizumab Production Value by Application (2027-2032) & (USD Million)
Table 80. World Mepolizumab Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World Mepolizumab Average Price by Application (2027-2032) & (US$/Unit)
Table 82. GSK, GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 83. GSK, GlaxoSmithKline Major Business
Table 84. GSK, GlaxoSmithKline Mepolizumab Product and Services
Table 85. GSK, GlaxoSmithKline Mepolizumab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. GSK, GlaxoSmithKline Recent Developments/Updates
Table 87. GSK, GlaxoSmithKline Competitive Strengths & Weaknesses
Table 88. Global Key Players of Mepolizumab Upstream (Raw Materials)
Table 89. Global Mepolizumab Typical Customers
Table 90. Mepolizumab Typical Distributors
LIST OF FIGURES
Figure 1. Mepolizumab Picture
Figure 2. World Mepolizumab Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Mepolizumab Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Mepolizumab Production (2021-2032) & (Units)
Figure 5. World Mepolizumab Average Price (2021-2032) & (US$/Unit)
Figure 6. World Mepolizumab Production Value Market Share by Region (2021-2032)
Figure 7. World Mepolizumab Production Market Share by Region (2021-2032)
Figure 8. North America Mepolizumab Production (2021-2032) & (Units)
Figure 9. Europe Mepolizumab Production (2021-2032) & (Units)
Figure 10. China Mepolizumab Production (2021-2032) & (Units)
Figure 11. Japan Mepolizumab Production (2021-2032) & (Units)
Figure 12. India Mepolizumab Production (2021-2032) & (Units)
Figure 13. Mepolizumab Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Mepolizumab Consumption (2021-2032) & (Units)
Figure 16. World Mepolizumab Consumption Market Share by Region (2021-2032)
Figure 17. United States Mepolizumab Consumption (2021-2032) & (Units)
Figure 18. China Mepolizumab Consumption (2021-2032) & (Units)
Figure 19. Europe Mepolizumab Consumption (2021-2032) & (Units)
Figure 20. Japan Mepolizumab Consumption (2021-2032) & (Units)
Figure 21. South Korea Mepolizumab Consumption (2021-2032) & (Units)
Figure 22. ASEAN Mepolizumab Consumption (2021-2032) & (Units)
Figure 23. India Mepolizumab Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Mepolizumab by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Mepolizumab Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Mepolizumab Markets in 2025
Figure 27. United States VS China: Mepolizumab Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Mepolizumab Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Mepolizumab Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Mepolizumab Production Market Share 2025
Figure 31. China Based Manufacturers Mepolizumab Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Mepolizumab Production Market Share 2025
Figure 33. World Mepolizumab Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Mepolizumab Production Value Market Share by Type in 2025
Figure 35. 100mg Pre?filled Syringe
Figure 36. 100mg Lyophilized Powder for Injection
Figure 37. World Mepolizumab Production Market Share by Type (2021-2032)
Figure 38. World Mepolizumab Production Value Market Share by Type (2021-2032)
Figure 39. World Mepolizumab Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Mepolizumab Production Value by Combination Therapy, (USD Million), 2021 & 2025 & 2032
Figure 41. World Mepolizumab Production Value Market Share by Combination Therapy in 2025
Figure 42. Combination of Mepolizumab and Inhaled Corticosteroids
Figure 43. Combination of Mepolizumab and LABA
Figure 44. World Mepolizumab Production Market Share by Combination Therapy (2021-2032)
Figure 45. World Mepolizumab Production Value Market Share by Combination Therapy (2021-2032)
Figure 46. World Mepolizumab Average Price by Combination Therapy (2021-2032) & (US$/Unit)
Figure 47. World Mepolizumab Production Value by Route of Administratio, (USD Million), 2021 & 2025 & 2032
Figure 48. World Mepolizumab Production Value Market Share by Route of Administratio in 2025
Figure 49. Subcutaneous Injection
Figure 50. Subcutaneous Infusion
Figure 51. World Mepolizumab Production Market Share by Route of Administratio (2021-2032)
Figure 52. World Mepolizumab Production Value Market Share by Route of Administratio (2021-2032)
Figure 53. World Mepolizumab Average Price by Route of Administratio (2021-2032) & (US$/Unit)
Figure 54. World Mepolizumab Production Value by Sales Channel, (USD Million), 2021 & 2025 & 2032
Figure 55. World Mepolizumab Production Value Market Share by Sales Channel in 2025
Figure 56. Hospital
Figure 57. Retail
Figure 58. Online
Figure 59. World Mepolizumab Production Market Share by Sales Channel (2021-2032)
Figure 60. World Mepolizumab Production Value Market Share by Sales Channel (2021-2032)
Figure 61. World Mepolizumab Average Price by Sales Channel (2021-2032) & (US$/Unit)
Figure 62. World Mepolizumab Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 63. World Mepolizumab Production Value Market Share by Application in 2025
Figure 64. Severe Eosinophilic Asthma
Figure 65. Chronic Rhinosinusitis With Nasal Polyps
Figure 66. Eosinophilic Granulomatosis With Polyangiitis
Figure 67. Others
Figure 68. World Mepolizumab Production Market Share by Application (2021-2032)
Figure 69. World Mepolizumab Production Value Market Share by Application (2021-2032)
Figure 70. World Mepolizumab Average Price by Application (2021-2032) & (US$/Unit)
Figure 71. Mepolizumab Industry Chain
Figure 72. Mepolizumab Procurement Model
Figure 73. Mepolizumab Sales Model
Figure 74. Mepolizumab Sales Channels, Direct Sales, and Distribution
Figure 75. Methodology
Figure 76. Research Process and Data Source
Figure 1. Mepolizumab Picture
Figure 2. World Mepolizumab Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Mepolizumab Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Mepolizumab Production (2021-2032) & (Units)
Figure 5. World Mepolizumab Average Price (2021-2032) & (US$/Unit)
Figure 6. World Mepolizumab Production Value Market Share by Region (2021-2032)
Figure 7. World Mepolizumab Production Market Share by Region (2021-2032)
Figure 8. North America Mepolizumab Production (2021-2032) & (Units)
Figure 9. Europe Mepolizumab Production (2021-2032) & (Units)
Figure 10. China Mepolizumab Production (2021-2032) & (Units)
Figure 11. Japan Mepolizumab Production (2021-2032) & (Units)
Figure 12. India Mepolizumab Production (2021-2032) & (Units)
Figure 13. Mepolizumab Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Mepolizumab Consumption (2021-2032) & (Units)
Figure 16. World Mepolizumab Consumption Market Share by Region (2021-2032)
Figure 17. United States Mepolizumab Consumption (2021-2032) & (Units)
Figure 18. China Mepolizumab Consumption (2021-2032) & (Units)
Figure 19. Europe Mepolizumab Consumption (2021-2032) & (Units)
Figure 20. Japan Mepolizumab Consumption (2021-2032) & (Units)
Figure 21. South Korea Mepolizumab Consumption (2021-2032) & (Units)
Figure 22. ASEAN Mepolizumab Consumption (2021-2032) & (Units)
Figure 23. India Mepolizumab Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Mepolizumab by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Mepolizumab Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Mepolizumab Markets in 2025
Figure 27. United States VS China: Mepolizumab Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Mepolizumab Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Mepolizumab Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Mepolizumab Production Market Share 2025
Figure 31. China Based Manufacturers Mepolizumab Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Mepolizumab Production Market Share 2025
Figure 33. World Mepolizumab Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Mepolizumab Production Value Market Share by Type in 2025
Figure 35. 100mg Pre?filled Syringe
Figure 36. 100mg Lyophilized Powder for Injection
Figure 37. World Mepolizumab Production Market Share by Type (2021-2032)
Figure 38. World Mepolizumab Production Value Market Share by Type (2021-2032)
Figure 39. World Mepolizumab Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Mepolizumab Production Value by Combination Therapy, (USD Million), 2021 & 2025 & 2032
Figure 41. World Mepolizumab Production Value Market Share by Combination Therapy in 2025
Figure 42. Combination of Mepolizumab and Inhaled Corticosteroids
Figure 43. Combination of Mepolizumab and LABA
Figure 44. World Mepolizumab Production Market Share by Combination Therapy (2021-2032)
Figure 45. World Mepolizumab Production Value Market Share by Combination Therapy (2021-2032)
Figure 46. World Mepolizumab Average Price by Combination Therapy (2021-2032) & (US$/Unit)
Figure 47. World Mepolizumab Production Value by Route of Administratio, (USD Million), 2021 & 2025 & 2032
Figure 48. World Mepolizumab Production Value Market Share by Route of Administratio in 2025
Figure 49. Subcutaneous Injection
Figure 50. Subcutaneous Infusion
Figure 51. World Mepolizumab Production Market Share by Route of Administratio (2021-2032)
Figure 52. World Mepolizumab Production Value Market Share by Route of Administratio (2021-2032)
Figure 53. World Mepolizumab Average Price by Route of Administratio (2021-2032) & (US$/Unit)
Figure 54. World Mepolizumab Production Value by Sales Channel, (USD Million), 2021 & 2025 & 2032
Figure 55. World Mepolizumab Production Value Market Share by Sales Channel in 2025
Figure 56. Hospital
Figure 57. Retail
Figure 58. Online
Figure 59. World Mepolizumab Production Market Share by Sales Channel (2021-2032)
Figure 60. World Mepolizumab Production Value Market Share by Sales Channel (2021-2032)
Figure 61. World Mepolizumab Average Price by Sales Channel (2021-2032) & (US$/Unit)
Figure 62. World Mepolizumab Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 63. World Mepolizumab Production Value Market Share by Application in 2025
Figure 64. Severe Eosinophilic Asthma
Figure 65. Chronic Rhinosinusitis With Nasal Polyps
Figure 66. Eosinophilic Granulomatosis With Polyangiitis
Figure 67. Others
Figure 68. World Mepolizumab Production Market Share by Application (2021-2032)
Figure 69. World Mepolizumab Production Value Market Share by Application (2021-2032)
Figure 70. World Mepolizumab Average Price by Application (2021-2032) & (US$/Unit)
Figure 71. Mepolizumab Industry Chain
Figure 72. Mepolizumab Procurement Model
Figure 73. Mepolizumab Sales Model
Figure 74. Mepolizumab Sales Channels, Direct Sales, and Distribution
Figure 75. Methodology
Figure 76. Research Process and Data Source
